BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38064864)

  • 1. Health-related quality of life thresholds of clinical importance at diagnosis can predict longitudinal post-operative health functioning in colorectal cancer patients: A prospective multicentre observational study.
    Lau J; Khoo AM; ; Luo N; Tan KK
    Eur J Surg Oncol; 2024 Jan; 50(1):107291. PubMed ID: 38064864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
    Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
    Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life measures (EORTC QLQ-C30 and SF-36) as predictors of survival in palliative colorectal and lung cancer patients.
    Grande GE; Farquhar MC; Barclay SI; Todd CJ
    Palliat Support Care; 2009 Sep; 7(3):289-97. PubMed ID: 19788770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thresholds for clinical importance were established to improve interpretation of the EORTC QLQ-C30 in clinical practice and research.
    Giesinger JM; Loth FLC; Aaronson NK; Arraras JI; Caocci G; Efficace F; Groenvold M; van Leeuwen M; Petersen MA; Ramage J; Tomaszewski KA; Young T; Holzner B;
    J Clin Epidemiol; 2020 Feb; 118():1-8. PubMed ID: 31639445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal analysis of quality of life in primary lung cancer patients with chlamydia pneumoniae infection: a time-to-deterioration model.
    Chen Z; Zhuang J; Liu M; Xu X; Liu Y; Yang S; Xie J; Lin N; Lai F; He F
    BMC Pulm Med; 2024 Jan; 24(1):36. PubMed ID: 38233781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thresholds for clinical importance for four key domains of the EORTC QLQ-C30: physical functioning, emotional functioning, fatigue and pain.
    Giesinger JM; Kuijpers W; Young T; Tomaszewski KA; Friend E; Zabernigg A; Holzner B; Aaronson NK
    Health Qual Life Outcomes; 2016 Jun; 14():87. PubMed ID: 27267486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxiety, depression, health-related quality of life, and mortality among colorectal patients: 5-year follow-up.
    Orive M; Anton-Ladislao A; Lázaro S; Gonzalez N; Bare M; Fernandez de Larrea N; Redondo M; Bilbao A; Sarasqueta C; Aguirre U; Quintana JM;
    Support Care Cancer; 2022 Oct; 30(10):7943-7954. PubMed ID: 35737143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recovery of health-related quality of life in patients undergoing robot-assisted radical cystectomy with intracorporeal diversion.
    Abozaid M; Tan WS; Khetrapal P; Baker H; Duncan J; Sridhar A; Briggs T; Selim M; Abdallah MM; Elmahdy AA; Elserafy F; Kelly JD
    BJU Int; 2022 Jan; 129(1):72-79. PubMed ID: 34092021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does it matter how we evaluate HRQOL? Longitudinal comparison of the EORTC QLQ-C30/QLQ-OG25 and FACT-E.
    Darling GE; Sulman J; Espin-Garcia O; Trudel JG; Atenafu EG; Kidane B
    J Cancer Surviv; 2021 Aug; 15(4):641-650. PubMed ID: 33106994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clustering of EORTC QLQ-C30 health-related quality of life scales across several cancer types: Validation study.
    Machingura A; Taye M; Musoro J; Ringash J; Pe M; Coens C; Martinelli F; Tu D; Basch E; Brandberg Y; Grønvold M; Eggermont A; Cardoso F; Van Meerbeeck J; van der Graaf WTA; Taphoorn M; Reijneveld JC; Soffietti R; Sloan J; Velikova G; Flechtner H; Bottomley A;
    Eur J Cancer; 2022 Jul; 170():1-9. PubMed ID: 35569438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma - clinical application of health-related quality-of-life data.
    Li L; Mo FK; Chan SL; Hui EP; Tang NS; Koh J; Leung LK; Poon AN; Hui J; Chu CM; Lee KF; Ma BB; Lai PB; Chan AT; Yu SC; Yeo W
    BMC Cancer; 2017 Jan; 17(1):8. PubMed ID: 28052758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between physical activity and health-related quality of life: time to deterioration model analysis in lung adenocarcinoma.
    Zhuang J; Liu Y; Xu X; Cai Y; Liu M; Chen Z; Yang S; Lin J; Hu Z; Kang M; Lin M; He F
    J Cancer Surviv; 2023 Dec; 17(6):1769-1779. PubMed ID: 36192668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The validation of the standard Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire 30 (EORTC QLQ-C30) in pre-operative patients with brain tumor in China.
    Cheng JX; Liu BL; Zhang X; Zhang YQ; Lin W; Wang R; Zhang YQ; Zhang HY; Xie L; Huo JL
    BMC Med Res Methodol; 2011 Apr; 11():56. PubMed ID: 21513533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular health-related quality of life in cancer: a prospective study comparing the ESC HeartQoL and EORTC QLQ-C30 questionnaire.
    Anker MS; Potthoff SK; Lena A; Porthun J; Hadzibegovic S; Evertz R; Denecke C; Fröhlich AK; Sonntag F; Regitz-Zagrosek V; Rosen SD; Lyon AR; Lüscher TF; Spertus JA; Anker SD; Karakas M; Bullinger L; Keller U; Landmesser U; Butler J; von Haehling S
    Eur J Heart Fail; 2023 Sep; 25(9):1635-1647. PubMed ID: 37369985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimally important differences for interpreting the EORTC QLQ-C30 in patients with advanced colorectal cancer treated with chemotherapy.
    Musoro JZ; Sodergren SC; Coens C; Pochesci A; Terada M; King MT; Sprangers MAG; Groenvold M; Cocks K; Velikova G; Flechtner HH; Bottomley A;
    Colorectal Dis; 2020 Dec; 22(12):2278-2287. PubMed ID: 32767619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Updated normative data for the EORTC QLQ-C30 in the general Dutch population by age and sex: a cross-sectional panel research study.
    de Ligt KM; Aaronson NK; Liegl G; Nolte S;
    Qual Life Res; 2023 Sep; 32(9):2477-2487. PubMed ID: 37031427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychometric validation of the Moroccan version of the EORTC QLQ-C30 in colorectal Cancer patients: cross-sectional study and systematic literature review.
    El Alami Y; Essangri H; Majbar MA; Boutayeb S; Benamr S; El Malki HO; Souadka A
    BMC Cancer; 2021 Jan; 21(1):99. PubMed ID: 33499819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The EORTC QLQ-C30 Summary Score as Prognostic Factor for Survival of Patients with Cancer in the "Real-World": Results from the Population-Based PROFILES Registry.
    Husson O; de Rooij BH; Kieffer J; Oerlemans S; Mols F; Aaronson NK; van der Graaf WTA; van de Poll-Franse LV
    Oncologist; 2020 Apr; 25(4):e722-e732. PubMed ID: 32297435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal associations of light-intensity physical activity with quality of life, functioning and fatigue after colorectal cancer.
    van Roekel EH; Duchâteau J; Bours MJL; van Delden L; Breedveld-Peters JJL; Koole JL; Kenkhuis M; van den Brandt PA; Jansen RL; Kant I; Lima Passos V; Meijer K; Breukink SO; Janssen-Heijnen MLG; Keulen E; Weijenberg MP
    Qual Life Res; 2020 Nov; 29(11):2987-2998. PubMed ID: 32617891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consistency matters: measurement invariance of the EORTC QLQ-C30 questionnaire in patients with hematologic malignancies.
    Sommer K; Cottone F; Aaronson NK; Fayers P; Fazi P; Rosti G; Angelucci E; Gaidano G; Venditti A; Voso MT; Baccarani M; Vignetti M; Efficace F
    Qual Life Res; 2020 Mar; 29(3):815-823. PubMed ID: 31782016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.